
News from manchesterjournal.com
Information about manchesterjournal.com
Where is manchesterjournal.com located?manchesterjournal.com's WebsiteMedia Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top manchesterjournal.com News

Shenzhen · ShenzhenSHENZHEN, China, June 3, 2025 /PRNewswire/ -- The 2025 International Image Culture Week kicked off in Shenzhen with the highly anticipated 2025 SmallRig Awards Ceremony, where 22 prestigious awards were presented to exceptional global creators. The 2025 International Image Culture Week covers three main sections: 2025 Visionary Storytellers Industry Forum, SmallRig Awards Ceremony, and public image experience activities such as The Social Impact…See the Story
Witness the power of images to change the world: The First SmallRig Awards Announce 22 Global Winners
58% Center coverage: 34 sources

Artificial Intelligence · TokyoTOKYO, June 3, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced its participation in the Total Solution Exhibition for Electronic Equipment 2025 (JPCA Show 2025), taking place from June 4-6 at the Tokyo Big Sight East Exhibition Halls. At Booth #6C-03,…See the Story
DuPont Powers AI and Next-Gen Electronics with Advanced Interconnect Innovations at JPCA Show 2025
64% Center coverage: 28 sources
US Aluminum Tariffs Risk Supply Chain And Food Security, Industry Insiders Warn - Anheuser-Busch InBev (NYSE:BUD), Ambev (NYSE:ABEV)
62% Center coverage: 27 sources
Daewoong Pharmaceutical Presents Phase 2 Clinical Trial Poster on 'Bersiporocin' at ATS 2025, Highlights Global Patient Demographics
62% Center coverage: 26 sources
Three years in, BBA girls Ultimate reaches new heights
Swampscott students have a field day
Ascletis Announces Phase III Trial of Denifanstat (ASC40), a First-in-Class, Once-Daily Oral FASN Inhibitor for Acne, Meets All Endpoints
61% Center coverage: 28 sources
Airbnb Provides Copies of Stockholder Complaint and Alleged Stockholder Proposals
58% Center coverage: 24 sources
BioVaxys Issues Corporate Update
60% Center coverage: 15 sources
RAM Partners Earns Top 4 National Ranking for Online Reputation in Multifamily Industry, Top 10 for 11 consecutive years
64% Center coverage: 28 sources